Literature DB >> 34845574

Micafungin Population PK Analysis in Healthy and Septic Pigs: Can the Septic Porcine Model Predict the Micafungin PK in Septic Patients?

Nicolas Garbez1,2,3, Litaty C Mbatchi4,5, Guillaume Louart6,7, Steven C Wallis8, Laurent Muller6,7, Jeffrey Lipman7,8,9, Jason A Roberts7,8,9,10,11, Jean-Yves Lefrant6,7, Claire Roger6,7.   

Abstract

OBJECTIVES: To describe micafungin pharmacokinetic (PK) alterations of sepsis induced in piglets and to determine whether the porcine septic model is able to predict the PK of micafungin in septic patients at the plasma and peritoneal sites.
METHODS: From healthy (n = 8) and septic piglet group (n = 16), total micafungin concentrations were subject to a population PK analysis using Monolix®. Data from 16 septic humans patients from others studies was used to compare micafungin PK between septic piglets and septic patients.
RESULTS: Sepsis induced in piglets slightly alters the total clearance and the volume of distribution, while inter-compartment clearance is increased (from 3.88 to 5.74 L/h) as well as the penetration into peritoneal cavity (from 61 to 90%). In septic human patients, PK parameters are similar except for the Vd, which is corrected by an allometric factor based on the body weight of each species. Micafungin penetration into peritoneal cavity of humans is lower than in septic piglets (40 versus 90%).
CONCLUSIONS: The sepsis induced in the porcine model alters the PK of micafungin comparable to that in humans. In addition, micafungin PK is similar between these two species at the plasma level taking into account the allometric relationship of the body weight of these species on the central volume of distribution. The porcine septic plasma model would be able to predict the micafungin PK in the septic patients. However, further studies on peritoneal penetration are necessary to characterize this inter-species difference.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  cross-species extrapolation; echinocandins; pharmacokinetics modelling; piglet model; sepsis

Mesh:

Substances:

Year:  2021        PMID: 34845574     DOI: 10.1007/s11095-021-03137-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  1 in total

1.  The three Rs: the way forward: the report and recommendations of ECVAM Workshop 11.

Authors:  Michael Balls; Alan M Goldberg; Julia H Fentem; Caren L Broadhead; Rex L Burch; Michael F W Festing; John M Frazier; Coenraad F M Hendriksen; Margaret Jennings; Margot D O van der Kamp; David B Morton; Andrew N Rowan; Claire Russell; William M S Russell; Horst Spielmann; Martin L Stephens; William S Stokes; Donald W Straughan; James D Yager; Joanne Zurlo; Bert F M van Zutphen
Journal:  Altern Lab Anim       Date:  1995 Nov-Dec       Impact factor: 1.303

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.